These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7059632)
41. The sensitivity and specificity of the DST in child psychiatric disorders. Sellman D; Ney P Aust N Z J Psychiatry; 1984 Sep; 18(3):289. PubMed ID: 6593063 [No Abstract] [Full Text] [Related]
42. Psychobiological markers in secondary depression. Thase ME Am J Psychiatry; 1983 Jun; 140(6):816-7. PubMed ID: 6846650 [No Abstract] [Full Text] [Related]
43. The dexamethasone suppression test: some limitations in the general hospital setting. Baron DA; Shea S; White K J Am Osteopath Assoc; 1984 Mar; 83(7):505-8. PubMed ID: 6706716 [No Abstract] [Full Text] [Related]
44. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. Rush AJ; Giles DE; Roffwarg HP; Parker CR Biol Psychiatry; 1982 Mar; 17(3):327-41. PubMed ID: 7082700 [TBL] [Abstract][Full Text] [Related]
46. Recent research on the DST. Pitts FN J Clin Psychiatry; 1984 Sep; 45(9):380-1. PubMed ID: 6469921 [No Abstract] [Full Text] [Related]
47. An amphetamine-like reaction to the dexamethasone suppression test in depressed patients. Sovner R J Clin Psychopharmacol; 1983 Aug; 3(4):236-8. PubMed ID: 6886036 [No Abstract] [Full Text] [Related]
48. Preliminary report on the dexamethasone suppression test in adolescents. Robbins DR; Alessi NE; Yanchyshyn GW; Colfer MV Am J Psychiatry; 1982 Jul; 139(7):942-3. PubMed ID: 7091415 [No Abstract] [Full Text] [Related]
49. The validity of the DST. Zimmerman M J Clin Psychiatry; 1985 Mar; 46(3):110. PubMed ID: 3972778 [No Abstract] [Full Text] [Related]
50. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Reus VI Biol Psychiatry; 1982 Mar; 17(3):317-26. PubMed ID: 7082699 [TBL] [Abstract][Full Text] [Related]
51. d-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression. Ettigi PG; Hayes PE; Narasimhachari N; Hamer RM; Goldberg S; Secord GJ Biol Psychiatry; 1983 Apr; 18(4):499-504. PubMed ID: 6860724 [No Abstract] [Full Text] [Related]
52. Cortisol suppression index: a new approach to interpreting the DST in depression. Bernstein JP; Chung SY; Avila KS J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249 [TBL] [Abstract][Full Text] [Related]
53. Normalization of dexamethasone test associated with social support system improvement. Schwartz LS Psychiatr J Univ Ott; 1984 Mar; 9(1):45-6. PubMed ID: 6374718 [No Abstract] [Full Text] [Related]
54. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings]. Brown WA; Haier RJ; Qualls CB Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667 [No Abstract] [Full Text] [Related]
55. The dexamethasone suppression test in two patients with severe depressive pseudodementia. McAllister TW; Ferrell RB; Price TR; Neville MB Am J Psychiatry; 1982 Apr; 139(4):479-81. PubMed ID: 7065293 [No Abstract] [Full Text] [Related]
57. Methodological standards in studies evaluating the dexamethasone suppression test. Davies J; Hall J; McFarlane A Aust N Z J Psychiatry; 1984 Sep; 18(3):273-6. PubMed ID: 6593059 [TBL] [Abstract][Full Text] [Related]